KB304 for Neck Wrinkles
(Pearl-2 Trial)
Trial Summary
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.
What data supports the effectiveness of the treatment KB304 for neck wrinkles?
The research suggests that treatments like botulinum toxin type A and other topical products with active ingredients such as retinol and hyaluronic acid have shown effectiveness in reducing neck wrinkles and improving skin appearance. These findings may indirectly support the potential effectiveness of KB304 if it contains similar components or mechanisms.12345
How is the treatment KB304 different from other treatments for neck wrinkles?
What is the purpose of this trial?
The aim of this study is to investigate the safety and efficacy of KB304, an investigational gene therapy to correct moderate to severe wrinkles in the décolleté region (V-shaped chest area). KB304 is an investigational gene therapy that delivers functional, full-length human collagen (COL3) and elastin (tropoelastin) to the skin through small injections using the Sponsor's genetically engineered Herpes Simplex Virus (HSV-1) vector. The study is a randomized double-blind study and participants will receive either KB304 (active group) or placebo (inactive group).
Eligibility Criteria
This trial is for women with moderate to severe wrinkles in the décolleté region. Participants should be healthy and looking to improve skin appearance. Specific eligibility details are not provided, but typically include age range and absence of certain health conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive KB304 or placebo through intradermal injections to assess safety and efficacy for wrinkle treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- KB304
Find a Clinic Near You
Who Is Running the Clinical Trial?
Krystal Biotech, Inc.
Lead Sponsor